When.com Web Search

  1. Ads

    related to: what is menotropin generic

Search results

  1. Results From The WOW.Com Content Network
  2. Menotropin - Wikipedia

    en.wikipedia.org/wiki/Menotropin

    Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins .

  3. Gonadotropin preparations - Wikipedia

    en.wikipedia.org/wiki/Gonadotropin_Preparations

    Generic. menotropins for injections, USP. Brands. Menopur, 5 mL vials containing 75 IU FSH and 75 IU LH. Repronex, vials containing either 75 IU FSH and 75 IU LH, or ...

  4. Urofollitropin - Wikipedia

    en.wikipedia.org/wiki/Urofollitropin

    Urofollitropin is a purified form of follicle-stimulating hormone (FSH) that is manufactured by extraction from human urine and then purified [1] to remove various proteins and other substances.

  5. Gonadotropin-releasing hormone agonist - Wikipedia

    en.wikipedia.org/wiki/Gonadotropin-releasing...

    A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones. [1] They are used for a variety of indications including in fertility medicine and to lower sex hormone levels in the treatment of hormone-sensitive cancers such as prostate cancer and breast cancer, certain gynecological disorders like heavy periods and endometriosis ...

  6. List of investigational sexual dysfunction drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_investigational...

    Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. This list was last comprehensively updated in June 2017. It is likely to become outdated with time.

  7. What Medicare beneficiaries need to know about generic ... - AOL

    www.aol.com/finance/medicare-beneficiaries-know...

    “In 2011, 73% of generic medications covered in Medicare Part D were placed on Tier 1, where cost-sharing [by beneficiaries] averages out to zero. In 2021, that dropped to 15%,” says Sargent.